This inventor holds 8 USPTO granted patents and 14 published patent applications and 18 EPO patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Eric Smith - Innovator in Antigen-Binding Molecules
Introduction
Eric Smith is an inventor based in New York, NY (US), currently working at Regeneron Pharmaceuticals, Inc. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding molecules. Although he does not hold any granted patents, his work is focused on innovative applications that have the potential to impact therapeutic strategies.
Latest Patent Applications
Eric Smith's latest patent applications include:
1. **Multispecific Binding Molecule Proproteins and Uses Thereof** - This application provides proproteins of antigen-binding molecules, including multispecific binding molecules (MBMs). The antigen-binding molecule proproteins comprise an antigen-binding site, components that inhibit the binding of the antigen-binding site to its target, and a protease-cleavable linker. The disclosure further provides pharmaceutical compositions comprising the antigen-binding molecule proproteins, methods of use in therapy, and nucleic acids encoding the antigen-binding molecule proproteins.
2. **Antigen Binding Molecule Formats** - This application describes antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates, and pharmaceutical compositions containing the ABMs. It also outlines methods for using the ABMs and ABM conjugates for treating cancer, as well as methods of producing ABMs.
Conclusion
Eric Smith is a dedicated inventor whose work at Regeneron Pharmaceuticals, Inc. focuses on advancing the field of antigen-binding molecules. His latest patent applications reflect his commitment to developing innovative therapeutic solutions.